FORM 6-K

 

SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549

 

Report of Foreign Issuer

 

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934


For period ending May 21, 2008

GlaxoSmithKline plc
(Name of registrant)

 

980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)


Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F


Form 20-F x Form 40-F
 --


Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.

Yes No x
  --

 

Issued – Wednesday 21 May 2008, London - LSE Announcement

GlaxoSmithKline plc - Results of AGM

GlaxoSmithKline (GSK) announces that at today's Annual General Meeting all resolutions, including those electing and re-electing Board members, were passed by shareholders.
 
GlaxoSmithKline Annual General Meeting Poll Results
 
The following table shows the votes cast for each resolution:

Resolution

Total votes for *

%

Total votes against

%

Total votes cast

Votes withheld **

1

Adoption of Financial Statements

3,749,614,298

95.18

189,859,453

4.82

3,939,473,751

9,410,864

2

Approval of the Remuneration Report

2,423,411,670

85.89

398,271,204

14.11

2,821,682,874

1,127,201,561

3

Election of Mr Andrew Witty

3,877,718,934

99.23

29,969,659

0.77

3,907,688,593

41,195,842

4

Election of Mr Christopher Viehbacher

3,849,501,839

99.49

19,772,868

0.51

3,869,274,707

79,609,728

5

Election of Professor Sir Roy Anderson

3,909,528,117

99.82

7,050,023

0.18

3,916,578,140

32,306,295

6

Re-election of Sir Christopher Gent

3,810,072,560

98.08

74,773,259

1.92

3,884,845,819

64,038,616

7

Re-election of Sir Ian Prosser

3,907,565,196

99.77

9,050,718

0.23

3,916,615,914

32,268,521

8

Re-election of Dr Ronaldo Schmitz

3,899,485,674

99.56

17,139,141

0.44

3,916,624,815

32,259,620

9

Re-appointment of Auditors

3,877,708,481

99.54

17,936,334

0.46

3,895,644,815

53,239,620

10

Remuneration of Auditors

3,913,134,400

99.69

12,121,289

0.31

3,925,255,689

23,628,746

11

To authorise the company to make donations to Political Organisations & incur Political Expenditure

3,764,947,848

97.09

112,911,635

2.91

3,877,859,483

71,024,952

12

Authority to allot shares

3,877,961,825

98.44

61,623,083

1.56

3,939,584,908

9,299,527

13

Disapplication of pre-emption rights***

3,891,091,851

98.82

46,291,865

1.18

3,937,383,716

11,500,719

14

Authority for the Company to purchase its own shares ***

3,871,222,137

98.23

69,853,695

1.77

3,941,075,832

7,808,603

15

Adopt new Articles of Association ***

3,919,473,970

99.55

17,602,044

0.45

3,937,076,014

11,808,421


Notes:

*     Includes discretionary votes.

**     A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.
***     Indicates Special Resolutions requiring a 75% majority

The following table provides further relevant information: 

 

GlaxoSmithKline's
Eighth AGM
(2008)

GlaxoSmithKline's
Seventh AGM (2007)

Issued share capital
(excluding Treasury Shares)

5 , 352 ,175 , 102

5,725,158,425

Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares)

73.78%

73.68%

Total shareholder population

172,581

180,486

Total number of proxies lodged

12,896

14,357

% of shareholders who lodged proxies

7.47%

7.95%

Number of shareholders, corporate representatives and proxies who attended the AGM

266

276


S M Bicknell
Company Secretary
21 May 2008
 

These results will shortly be available on the Company's website www.gsk.com.
 

Enquiries:

UK Media

Philip Thomson
Alice Hunt

Gwenan White

(020) 8047 5502

(020) 8047 5502

(020) 8047 5502
       
 

US Media

Nancy Pekarek

Mary Anne Rhyne

(215) 751 7709

(919) 483 2839
       
 

European Analyst / Investor

David Mawdsley
Sally Ferguson
Gary Davies

(020) 8047 5564
(020) 8047 5543
(020) 8047 5503
       
 

US Analyst / Investor

Frank Murdolo
Tom Curry

(215) 751 7002
(215) 751 5419



 

SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

 

                                                             GlaxoSmithKline plc
                                                                    (Registrant)

Date: May 21, 2008                                                                                                              By: VICTORIA WHYTE
                                                                                                                                                                ------------------
                                                              Victoria Whyte
                                                 Authorised Signatory for and on
                                                   behalf of GlaxoSmithKline plc